ABSTRACT
SAŽETAK

Promenjen imunski odgovor na komensalne bakterije u gastrointestinalnom traktu je važan za patogenezu ulceroznog kolitisa. Galektin-3 (engl. Galectin-3, Gal-3) je endogeni lektin, koji igra važnu proinfl amacijsku ulogu u inicijalnoj fazi akutnog kolitisa, tako što promoviše aktivaciju NLRP3 infl amazoma i produkciju IL-1β u makrofagima. U ovom istraživanju ispitivan je uticaj Gal-3 na mikrofl oru u patogenezi akutnog kolitisa izazvanog dekstran natrijum sulfatom (engl. Dextran sulphate sodium, DSS). Delecija gena za Gal-3 je znacajno smanjila oštećenje tkiva kolona životinja tretiranih DSS-om. U poređenju sa WT miševima, u tkivu kolona DSS-tretiranih Gal-3 -/-životinja je bila značajno manja zastupljenost fagocita (neutrofi la, makrofaga i dendritskih ćelija) sto je koreliralo sa promenama u sastavu bakterijske crevne fl ore. Primenom antibiotika ublazio se razvoj akutnog kolitisa, ali bez uticaja na već postojeću razliku u bolesti između WT i Gal-3 -/-miševa. Gram negativna bakterijska fl ora igra važnu ulogu u akutnom kolitisu izazvanom DSS-ом, ali ne učestvuje u Gal-3 zavisnoj modulaciji infl amacije kolona.
INTRODUCTION
Ulcerative colitis (UC) is a chronic inflammatory disorder of the gastrointestinal tract (1) . The etiology of UC is still elusive, and many factors have been reported to be involved in the development of this disease, including epithelial cell destruction, genetic susceptibility and modulation of bacterial flora in the intestinal environment. Therefore, murine models have become essential tools to investigate the pathophysiological mechanisms and immunological processes underlying chronic mucosal inflammation in the colon (2) . Dextran sulphate sodium (DSS)-induced colitis is a frequently used animal model of UC (3) . Intestinal microflora play an important role in the susceptibility and responsiveness to DSS-induced colitis (4) . DSS induces mucosal injury and inflammation, initially through a direct toxic effect on epithelial cells, followed by invasion of intestinal bacteria into subepithelial tissue and subsequent recruitment and activation of inflammatory cells: neutrophils, macrophages, eosinophils, mast cells, dendritic cells (DCs), and NKT cells, accompanied by production of inflammatory mediators, and leading to the development of severe colitis (4).
Galectin-3 (Gal-3) is an endogenous lectin that exerts both pro-and anti-inflammatory effects, depending on the disease condition. It plays an important disease-exacerbating role in autoimmune/inflammatory and malignant diseases (5-9) but has a protective role in obesity-induced inflammation and type 2 diabetes, as well as in primary biliary cirrhosis (10, 11) . Recently, several clinical studies showed a correlation between the serum level of Gal-3 and exacerbation of acute colitis, indicating the importance of Gal-3 as a potential marker for this disease (12) (13) (14) . Serum concentrations of Gal-3 were significantly increased in specimens from patients with the active form of UC (12) . Recently, we showed that Gal-3 plays an important proinflammatory role in the induction phase of acute DSSinduced colitis by promoting activation of the NLRP3 inflammasome and production of IL-1β in macrophages (7) .
In this study, we investigated whether Gal-3 affects the function of colon infiltrating macrophages by interfering with intestinal microflora and whether these interactions are important in the development and progression of DSSinduced colitis.
MATERIALS AND METHODS
Animals
Male, 6-8-week-old wild type (WT) and Gal-3 -/-C57BL/6 mice (provided by Dr Daniel Hsu, University of California, Sacramento, CA) were used for the induction of DSS-induced colitis. Targeted disruption of the mouse Gal-3 gene was performed in C57BL/6 embryonic stem cells, and mice homozygous for the disrupted gene were obtained (15) 
Induction of acute colitis
Colitis was induced with 3% w/v DSS (molecular weight 40 kDa; TdB Consultancy, Uppsala, Sweden) dissolved in drinking water given ad libitum for up to 7 days, as previously described (3). Control mice were given DSS-free water.
Assessment of the severity of colitis
The Disease Activity Index (DAI) was used to assess clinical signs of colitis (16) . Body weight measurements, analysis of stool consistency, and faecal occult blood tests were performed daily. Body weight was measured daily and compared with the body weight measured on day 0 (the 1st day of DSS administration). The results are presented as ±% body weight loss.
Histology
For histological analysis, colons were removed from euthanised mice, rinsed with phosphate buffer solution (PBS), and cut longitudinally before being rolled into a 'Swiss roll' , as previously described (17) . Swiss rolled colons were fixed in formalin and embedded in paraffin, and 5-μm sections were stained with haematoxylin-eosin (H&E) and examined in a blinded manner by a pathologist. Sections were analysed for damage to the epithelium including damage to crypts, submucosal oedema, haemorrhage, and infiltration by immune cells. The histology score for each mouse was calculated as the sum of 'Infiltration' and 'Damage of Epithelium' sub-scores, as previously described (18) .
Flow cytometry analysis of colon infiltrating cells
Isolation of immune cells from the lamina propria and flow cytometry analysis were conducted as previously described (7). Briefly, each colon was dissected away from the caecum. The colon was cut into pieces 3 cm long and then cut longitudinally, so that 3 x 3 cm flaps of colonic tissue were made. The flaps were placed in a 50 ml conical tube and washed three to five times with 30 ml cold HBSS, calcium and magnesium free. After decanting the supernatant, the pieces were incubated in 20 ml HBSS/EDTA for 30 min in a 37°C water bath. Each tube was shaken regularly during the incubation to ensure that epithelial cells were disrupted from the mucosa. The pieces were sedimented, and the supernatant was decanted. The remaining EDTA was washed out with 40 ml HBSS, calcium and magnesium free. The fragments of colonic tissue were placed in a 5 cm Petri dish and cut into smaller pieces with a scalpel. The pieces were aspirated with a pipette, transferred to a fresh 50 ml conical tube and filled to 20 ml with Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% foetal bovine serum (FBS). Then, 1 ml of 4000 Mandl units (3 x 10 6 Wünsch units)/ml collagenase D and 200 μl of 1 mg/ml DNase were added to the tube and incubated for 1 h in a 37°C water bath. The supernatant was filtered through a 100 μm nylon cell strainer into a clean 50 ml conical tube. Cold HBSS, calcium and magnesium free, was added to a volume of 50 ml. Cells were pelleted by centrifuging 10 min at 450 g, at 4°C. The pellet was disrupted, and cells were re-suspended in 50 ml HBSS, calcium and magnesium free, and filtered through a 40-μm nylon cell strainer into a clean 50 ml conical tube. Cells were again pelleted by centrifuging 10 min at 450 g, at 4°C. The pellet was disrupted, and cells were re-suspended in 20 ml of 30% Percoll. Then, the cell suspension was carefully layered over 25 ml of 70% Percoll in a 50-ml conical tube and centrifuged for 20 min at 1100 x g, room temperature, with as low an acceleration rate as possible and with the brake off. Clumping of cells was prevented by the addition of 1 mM EDTA to the solution. Epithelial cells floated on the 30% Percoll layer, and immune cells were found between the 30% and 70% layers. Water with 3% DSS was given to mice for 7 days; regular drinking water was fed to control mice. Disease Activity Index (DAI) was scored at day 7 using the following parameters: weight loss, stool consistency, and rectal bleeding (A, B). Survival rate of mice with colitis (C). Histological examination was performed with haematoxylin and eosin (H&E) staining. H&E stained images of representative colon tissues are shown at the same magnifi cations (100x) (D, E). Data presented as the mean ± standard error of the mean (SEM); n = 10 mice per experimental group. *p<0.05, **p<0.001. Debris and dead cells were pelleted at the bottom of the conical tube.
Flow cytometry followed routine procedures by using 1x10 6 cells per sampwhichle, which were incubated with anti-mouse F4/80, CD11c, CD45, and Ly6G conjugated to fluorescein isothiocyanate (FITC; BD Biosciences, Franklin Lakes, NJ), or allophycocyanin (APC; BD Biosciences).
Flow cytometric analysis was conducted on a BD Biosciences FACSCalibur and analysed using the Flowing software analysis program.
Antibiotic treatment
To investigate the potential role of the microbiota and their relationship with Gal-3 in acute DSS-induced colitis, experimental animals received water supplemented with antibiotics. Mice were treated daily with antibiotics (metronidazole (1 mg/g) and ciprofloxacin (0.5 mg/g)), intraperitoneally injected from day 0 to the last day of the experiment. (19) . A fresh stool sample was collected in a clean tube and processed for bacteria determination. Samples were then placed in a special dish, which was filled with a gel that boosts the growth of bacteria, as previously described (20) .
Statistics
Data are expressed as the mean ± SEM for each group. We tested for normality using the Shapiro-Wilk's test and for homogeneity of variances using Levine's test. A paired samples t-test was used to compare the two matched groups. The independent samples Student's t-test was otherwise used to compare two groups with a Gaussian distribution. Fisher's exact test was used to assess survival differences between groups. Statistical analyses were performed using SPSS 21.0 for Windows (SPSS, Inc., Chicago, IL). All reported p values were 2-sided, p<0.05 was considered statistically significant, and p<0.001 was considered highly significant.
RESULTS
Genetic deletion of Gal-3 significantly attenuated DSS-induced colitis
Genetic deletion of Gal-3 attenuated DSS-induced colitis, according to the clinical parameters assessed ( Figure  1A) , loss of weight ( Figure 1B) , and the survival rate (Figure 1C) . All DSS treated WT mice developed severe colitis with similar clinical symptoms: diarrhoea, rectal bleeding, and weight loss. The presence of blood in the faeces was detected one to two days after the start of DSS treatment, whereas gross bleeding and diarrhoea were observed from day 4. Significant body weight loss (>5%) became prominent after five days of DSS treatment. These observations were confirmed by histological analysis ( Figure 1D ). The DSS-treated group clearly exhibited a severe mucosal inflammatory cell infiltration and a disruption of crypt architecture (epithelial ulcerations and loss of goblet cells), whereas lesions were prevented in Gal-3 -/-animals treated with DSS ( Figure 1E , low panel).
Gal-3 deletion significantly reduced the presence of phagocytic cells in DSS-injured colons
Genetic deletion of Gal-3 markedly decreased the numbers of neutrophils, dendritic cells and macrophages in colon tissue. Flow cytometry analysis showed a significantly lower percentage of CD45+Ly6G+ neutrophils, CD11c+ DCs and F4/80+ macrophages in colon tissue of DSS-treated Gal-3 -/-mice (Figure 2 ), indicating the important role that Gal-3 plays in the infiltration of phagocytic cells in DSS-injured colons.
To assess the differences in bacterial microflora between DSS-treated WT and Gal-3 -/-mice, microflora of the gut were analysed. There were no differences in Gram positive bacteria, while significant differences in Gram negative bacterial flora of the gut were observed. Enterococcus and Klebsiella species were found in both DSS-treated WT and Gal-3 -/-mice. Pseudomonas species were found only in the DSS-treated WT mice, while Escherichia coli and Proteus species were found only in the DSS-treated Gal-3 -/-mice ( Figure 3) . Antibiotic treatment significantly attenuated DSSinduced colitis without affecting differences between WT and Gal-3 -/-mice The use of antibiotics, which are effective against Gram negative bacteria (19), attenuated DSS-induced colitis, ameliorated diarrhoea and rectal bleeding, and reduced the loss of body weight ( Figure 4A, B) . Colon shortening was significantly lower in the DSS-treated Gal-3 -/-mice compared to the WT DSS-treated animals ( Figure 4C ). These findings were confirmed by histological analysis. In DSS-treated mice that received antibiotics, the colonic mucosa showed only slight pathological changes, including a reduced extent of colon damage and reduced infiltration of inflammatory cells ( Figure 4D ). The structure of the crypt epithelial cells remained intact, and the histopathological injury scores were significantly decreased when compared with DSS-only treated animals ( Figure  4D ). Most importantly, it appears that antibiotic treatment has a protective effect in DSS-induced colitis but does not affect the differences between the DSS-treated WT and Gal-3 -/-mice. The difference in clinical and histological parameters of DSS-induced colitis remained statistically significant between the antibiotic treated WT and Gal-3 -/-animals ( Figure 4 ).
DISCUSSION
There is increasing evidence that intestinal microflora play an important role in the pathogenesis of UC. Several studies in animal models of intestinal inflammation suggest that the inflammatory responses are triggered by normally nonpathogenic microbial flora. Bacteria are of prime importance for the onset of UC in IL-2-deficient mice, which are free of symptoms when they are kept in a germfree environment (21) . Additionally, IL-10-deficient mice develop an attenuated disease when they are kept in a facility with a defined microbial environment (22, 23) . Indirect evidence for the involvement of microorganisms in these findings includes the increased infiltration of phagocytic cells into the inflamed colons, which is followed by an uptake of luminal antigens (24) and the onset of inflammation in injured colons (24, 25) .
It is well known that Gal-3 is involved in migration of phagocytic cells (26, 27) . Accordingly, we found a significantly lower percentage of neutrophils, DCs and macrophages in the DSS-injured colons of Gal-3 -/-mice that was accompanied by a significant decrease in epithelial cell damage, oedema, ulceration and destruction of crypts ( Figure 1D, E) . These findings are in line with our recently published data in which we showed that Gal-3 promotes activation of the NLRP3 inflammasome and production of IL-1β in colon-infiltrating macrophages (7) and that pharmacological inhibition of Gal-3 enhances the capacity of mesenchymal stromal cells to promote alternative activation of macrophages in DSS-induced colitis (28) .
Several bacterial species were isolated from colons of UC patents, and some of them may modulate the activity of DSS, playing important roles in the induction of colitis (29, 30, 31 ). An increased number of Escherichia coli species were isolated from colons of UC patients (29, 30) . DSS is depolymerized in mouse faeces under aerobic conditions, and among all intestinal bacteria, Proteus mirabilis has the best ability to desulphonate and depolymerize DSS (32) . In line with these findings, we noticed a significantly higher presence of Escherichia Coli and Proteus species in DSS-treated Gal-3 -/-mice ( Figure 3 ) that correlated with attenuated disease in these animals.
Since metronidazole alone or in combination with ciprofloxacin may attenuate chronic TNBS-induced colitis in rats (33) and carrageenan-induced colitis in guinea pigs (34) , and since a combination of these antibiotics is effective against Gram negative bacteria such as Escherichia coli and Proteus, we used these antibiotics to determine the possible role of Gal-3 in the e interactions between intestinal microflora and the activity of phagocytic cells in acute colitis. We observed that the combination of metronidazole and ciprofloxacin significantly attenuated acute DSSinduced colitis in WT and Gal-3 -/-mice, as determined by clinical and histological scores (Figure 4) . Nevertheless, the differences in clinical and histological scores between DSS-injured WT and Gal-3 -/-mice were still evident in the antibiotic treated animals, indicating that the Gal-3 dependent decrease in the presence of phagocytic cells in the inflamed colons was not directly related to the content of intestinal microflora.
